The Moncrief Radiation Oncology Center provides state-of-the-art treatment for all stages of breast cancer including post-mastectomy irradiation, and breast conservation treatment with whole-breast irradiation and accelerated partial breast irradiation. Disease specific indications considered for treatment include intraductal carcinoma (also known as Ductal Carcinoma In-Situ, DCIS), Lobular Carcinoma In-Situ (LCIS), infiltrating (or invasive) ductal carcinoma, infiltrating (or invasive) lobular carcinoma, medullary carcinoma and sarcomas of the breast and chest wall.

For patients undergoing post-operative or whole breast treatment, radiation therapy is delivered with one of our three linear accelerators. Intensity Modulated Radiation Therapy (IMRT) is used to optimize coverage of the breast while decreasing the radiation delivered to the adjacent normal structures (including the heart and opposite breast). Accelerated partial breast irradiation using the MammoSite RTS implant system is available for carefully selected patients with early stage disease.

Moncrief Radiation Oncology Center is affiliated with UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center and interacts in multi-disciplinary consultation and management with medical oncologists and surgeons. We actively participate in clinical research when appropriate and offer patients the option of participating in trials offered by national collaborative groups (NSABP, RTOG and CALG-B), investigator-initiated and industry-sponsored trials.